#COVID19 $JNJ $EBS Janssen and Emergent BioSolutions announced a collab to support the manufacturing of J&amp;J’s lead investigational COVID-19 vaccine candidate.

This is the first in a series of prospective global collaboration agreements for these efforts.

https://t.co/YJ4cf7gbNk